KREMMIDIOTIS, GABRIEL,LAVRANOS, TINA,INGLIS, DANIEL
申请号：
CA2988604
公开号：
CA2988604A1
申请日:
2016.06.10
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The invention relates to pharmaceutical combinations comprising a vascular disrupting agent, in particular the tubulin polymerisation inhibitor BNC105, and an immunotherapeutic agent, in particular an anti-PD-L1, PD-1 or CTLA-4 antibody, and use thereof in the treatment of cancer.
